Perspective Therapeutics Inc

Research Perspective Therapeutics Inc (CATX) on Bullrun: market cap USD 404.86M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCATX
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 404.86M
• Financial periodFY2025
• Net income-USD 103.12M
• Free cash flow-USD 95.23M

Valuation Snapshot

latest market cap is USD 404.86M.

About Perspective Therapeutics Inc

Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Frequently asked questions

What is Perspective Therapeutics Inc's market cap?

Perspective Therapeutics Inc's market capitalization is USD 404.86M.

What does Perspective Therapeutics Inc do?

Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.